Automation & Q&M Technical Support at AGC Biologics

Bresso, Lombardy, Italy

AGC Biologics Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, CDMOIndustries

Requirements

  • Knowledge of instrumentation used in laboratory and production environments
  • Familiarity with quality management processes, particularly operational flows related to change control, deviation management, and CAPA implementation
  • Communication and relational skills to act as a strategic point of contact between internal users and external suppliers
  • Good knowledge of the English language

Responsibilities

  • Support the planning of interventions under Automation & Q&M responsibility
  • Support the preparation of documentation under Automation & Q&M responsibility (SOP, Technical Report, Qualification Summary, etc.)
  • Support the management of training for consultants/suppliers
  • Support the management of Changes, Deviations, and CAPA with impact on Automation & Q&M
  • Participate in regulatory inspections and customer audits

Skills

Automation
Q&M
SOP
Technical Report
Change Control
Deviations
CAPA
Quality Management
Laboratory Instrumentation
Production Environment
English

AGC Biologics

Contract development and manufacturing for biopharmaceuticals

About AGC Biologics

AGC Biologics specializes in the development and manufacturing of therapeutic proteins, plasmid DNA, viral vectors, and genetically engineered cells for the biopharmaceutical industry. The company provides end-to-end solutions, assisting clients from the initial development stages to full-scale production. Their services are particularly focused on fast-tracking projects for orphan drugs and rare diseases, which often require quicker timelines. AGC Biologics operates a network of advanced facilities across the U.S., Europe, and Asia, all adhering to strict quality regulations known as current Good Manufacturing Practices (cGMP). What sets AGC Biologics apart from competitors is its commitment to continuous innovation and its recent expansion to enhance capabilities in cell and gene therapy. The company's goal is to support biopharmaceutical companies in bringing new treatments to market efficiently and effectively.

Bothell, WashingtonHeadquarters
2001Year Founded
$613MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Risks

Restructuring and layoffs in Colorado indicate potential financial instability.
Leadership changes may disrupt ongoing projects and affect client trust.
Significant investment in Japan could strain financial resources and divert focus.

Differentiation

AGC Biologics specializes in therapeutic proteins, plasmid DNA, and viral vectors.
The company offers fast-track project capabilities for orphan drugs and rare diseases.
AGC Biologics operates globally with facilities in the U.S., Europe, and Asia.

Upsides

Increased demand for plasmid DNA boosts AGC's gene therapy and vaccine services.
Partnership with BioConnection enhances biodrug development capabilities, attracting more clients.
Expansion in Yokohama aligns with growing mRNA and cell therapy demand.

Land your dream remote job 3x faster with AI